CVS Stock Recent News

CVS Health has been named as a Top 25 dividend stock, according the most recent Dividend Channel ''DividendRank'' report. The report noted that among the coverage universe, CVS shares displayed both attractive valuation metrics and strong profitability metrics.

CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.

All commercial prescriptions dispensed at CVS Pharmacy will be reimbursed through CVS CostVantage starting this year  Innovative approach uses a transparent formula built on the drug acquisition cost, a set markup, and a fee to reflect the quality of pharmacy services provided  New reimbursement model supports future of retail pharmacy and paves the way for improved PBM transparency WOONSOCKET, R.I., Jan. 6, 2025 /PRNewswire/ -- Delivering on the promise of a simpler, more transparent, and more sustainable approach to retail pharmacy services, CVS Health® (NYSE: CVS) today announced that all of the commercial prescriptions dispensed through CVS Pharmacy® are contracted through the company's innovative CVS CostVantage reimbursement model starting this year.

WOONSOCKET, R.I. , Jan. 3, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

CVS Health tapped industry veteran David Joyner to become CEO and turnaround the struggling business.

CVS Health Corp (NYSE:CVS) shares plunged more than 7% in early trade as the pharmaceutical chain announced it is replacing its CEO Karen Lynch with company veteran David Joyner, effective immediately. Joyner has most recently served as executive vice president of CVS Health and president of CVS Caremark, bringing 37 years of health care and pharmacy benefit management experience, CVS said on Friday.

Shares of CVS dropped by 10% on Friday morning, pacing what would be the company's worst loss in three years, after the company replaced its chief executive while cutting its earnings projections well below analyst expectations.

CNBC's Joe Kernen reports on the latest news.

CVS Health Corp.'s stock tumbled 10.5% early Friday, after the healthcare company announced leadership changes and lowered guidance for the fourth time this year, weighed down by challenges in its health-benefits business.